Pathfinders in Biopharma

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Featured Biopharma Content

Why biopharma investment requires a different mindset

In the latest episode of Pathfinders, Noël Brown, Head of US Biotechnology Investment Banking at RBC Capital Markets, reveals why he’s feeling optimistic about M&A in biopharma and how leading in biotech investment and corporates needs visionary long-term thinking.

Listen NowRead Article

Read Time 23m

The Optimism Behind the Biopharma Market

Dr. Chen Yu, Founder and Managing Partner at TCG X, discusses why he is optimistic about biotech, and what’s happening behind the scenes in public and private markets.

Listen NowRead Article

Read Time 25m

Reimagining the Future of Biotech

In an era of accelerated change, it’s never been more important to reimagine where the future will take us. Drawing on proprietary research, RBC Imagine™ uncovers the transformational trends that will redefine biotech in years to come, pinpointing their impact on companies and investors.

Read Article

Read Time 4m

Pandemic Produced Lasting Changes in Medical Device Markets

Following RBC’s Global Healthcare Conference, BioWorld MedTech published an article about the top trends discussed that will continue to reshape healthcare and medtech.

Read Article

Read Time 3m

Outlook for Healthcare Services, IT and Devices Remains Strong

Despite macroeconomic challenges, healthcare remains a strong sector for investment. Labor headwinds and inflation may temper growth in the short term, but medium- and long-term outlooks and fundamentals remain intact.

Read Article

Read Time 4m

“Large pharma has $500B it could deploy for M&A.”

What are the challenges and opportunities for the healthcare sector post-pandemic? Where might we see innovations that drive M&A growth?

Watch VideoRead Article

Watch Time 4mRead Time 3m

Subscribe to Future Episodes of Pathfinders

Our podcast series explores the fast-moving world of Biopharma and what the road ahead looks like for companies and investors in the sector.

Subscribe Now

Recent Deals

A Leading Partner for the Biopharma Industry

Our specialty expertise, combined with outstanding execution, has resulted in recurring transactions for biopharma clients as we partner with them through each stage of their development and growth.

 

More from RBC Capital Markets

Stay Informed

Get the latest insights from RBC Capital Markets delivered to your inbox.